title: "What goes up must immediately come down!" Which indication for short-acting nifedipine in children with arterial hypertension?
authors.forename: A
authors.initials: A
authors.lastname: Calvetta
authors.forename: S
authors.initials: S
authors.lastname: Martino
authors.forename: R O
authors.initials: RO
authors.lastname: von Vigier
authors.forename: J
authors.initials: J
authors.lastname: Schmidtko
authors.forename: E
authors.initials: E
authors.lastname: Fossali
authors.forename: M G
authors.initials: MG
authors.lastname: Bianchetti
mesh_terms: D000293:Adolescent; D000328:Adult; D001783:Blood Flow Velocity / Q000187:drug effects / Q000502:physiology; D002648:Child; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D009543:Nifedipine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D014665:Vasodilator Agents; D009543:Nifedipine